Furthermore, a significant decrease in AMH concentrations and basal progesterone levels was observed in patients with T2DM (2.43 ± 2.31 vs. 3.58 ± 2.58, P<0.001; 0.28 ± 0.27 vs. 0.53 ± 0.46, P<0.001, respectively; Table 1). This evidence concerns the gene AMH and type 2 diabetes mellitus.